Wang WG - Search Results

1

Interdigitating dendritic cell sarcoma: Clinicopathologic study of 8 cases with review of the literature.

Xue T, Jiang XN, Wang WG, Zhou XY, Li XQ. Xue T, et al. Among authors: wang wg. Ann Diagn Pathol. 2018 Jun;34:155-160. doi: 10.1016/j.anndiagpath.2018.03.008. Epub 2018 Mar 30. Ann Diagn Pathol. 2018. PMID: 29660568 Free article. Review.

2

Anaplastic lymphoma kinase-positive large B-cell lymphoma: Clinico-pathological study of 17 cases with review of literature.

Jiang XN, Yu BH, Wang WG, Zhou XY, Li XQ. Jiang XN, et al. Among authors: wang wg. PLoS One. 2017 Jun 30;12(6):e0178416. doi: 10.1371/journal.pone.0178416. eCollection 2017. PLoS One. 2017. PMID: 28665943 Free PMC article. Review.

3

EBV-positive diffuse large B-cell lymphoma features PD-L1 protein but not mRNA overexpression.

Xue T, Wang WG, Zhou XY, Li XQ. Xue T, et al. Among authors: wang wg. Pathology. 2018 Dec;50(7):725-729. doi: 10.1016/j.pathol.2018.08.011. Epub 2018 Oct 30. Pathology. 2018. PMID: 30389217

4

Loss of B-cell receptor expression defines a subset of diffuse large B-cell lymphoma characterized by silent BCR/PI3K/AKT signaling and a germinal center phenotype displaying low-risk clinicopathologic features.

Wang WG, Cui WL, Wang L, Zhu F, Wan XC, Ping B, Zhou XY, Li XQ. Wang WG, et al. Among authors: wang l. Am J Surg Pathol. 2015 Jul;39(7):902-11. doi: 10.1097/PAS.0000000000000396. Am J Surg Pathol. 2015. PMID: 25970684

5

MYC Protein-positive Diffuse Large B-Cell Lymphoma Features an Activated B-Cell Receptor Signal Pathway.

Wang WG, Jiang XN, Liu ZB, Zhou XY, Li XQ. Wang WG, et al. Am J Surg Pathol. 2017 Apr;41(4):541-549. doi: 10.1097/PAS.0000000000000799. Am J Surg Pathol. 2017. PMID: 28291124

6

MYC protein dysregulation is driven by BCR-PI3K signalling in diffuse large B-cell lymphoma.

Wang WG, Liu ZB, Jiang XN, Lee J, Zhou XY, Li XQ. Wang WG, et al. Histopathology. 2017 Nov;71(5):778-785. doi: 10.1111/his.13287. Epub 2017 Sep 15. Histopathology. 2017. PMID: 28639315

7

Unmask the genetic backbone of ibrutinib-relapsed chronic lymphocytic leukemia progression and Richter transformation.

Wang WG, Zhou XY, Li XQ. Wang WG, et al. Ann Transl Med. 2018 Jun;6(11):234. doi: 10.21037/atm.2018.05.34. Ann Transl Med. 2018. PMID: 30023397 Free PMC article. No abstract available.

8

PD-L1 over-expression is driven by B-cell receptor signaling in diffuse large B-cell lymphoma.

Wang WG, Jiang XN, Sheng D, Sun CB, Lee J, Zhou XY, Li XQ. Wang WG, et al. Lab Invest. 2019 Oct;99(10):1418-1427. doi: 10.1038/s41374-019-0262-5. Epub 2019 Jun 13. Lab Invest. 2019. PMID: 31197205 Free article.

9

Alteration of Cholesterol Metabolism by Metformin Is Associated With Improved Outcome in Type II Diabetic Patients With Diffuse Large B-Cell Lymphoma.

Jiang XN, Zhang Y, Wang WG, Sheng D, Zhou XY, Li XQ. Jiang XN, et al. Among authors: wang wg. Front Oncol. 2021 Jun 14;11:608238. doi: 10.3389/fonc.2021.608238. eCollection 2021. Front Oncol. 2021. PMID: 34195068 Free PMC article.

10

[Grey zone lymphoma with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: clinicopathologic characterization of 16 cases showing different patterns].

Wang L, Wang W, Li X, Guo Y, Zhu X. Wang L, et al. Zhonghua Bing Li Xue Za Zhi. 2014 May;43(5):307-12. Zhonghua Bing Li Xue Za Zhi. 2014. PMID: 25030862 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

351 results

Search Page

Filters